Literature DB >> 10482956

Molecular analysis of cystinosis: probable Irish origin of the most common French Canadian mutation.

J McGowan-Jordan1, K Stoddard, L Podolsky, E Orrbine, P McLaine, M Town, P Goodyer, A MacKenzie, H Heick.   

Abstract

Infantile nephropathic cystinosis, an autosomal recessive disease characterized by a lysosomal accumulation of cystine, presents as failure to thrive, rickets and proximal renal tubular acidosis. The cystinosis gene, CTNS, which maps to chromosome 17p13, encodes a predicted 55 kDa protein with characteristics of a lysosomal membrane protein. We have conducted extensive linkage analysis in a French Canadian cystinosis cohort identifying a founding haplotype present in approximately half (21/40) of the chromosomes studied. Subsequent mutational analysis, in addition to identifying two novel mutations, has unexpectedly revealed a mutation which has been previously found in Irish (but not French) cystinotic families on these 21 French Canadian chromosomes. Haplotype analysis of two Irish families with this mutation supports the hypothesis that Celtic chromosomes represent an extensive portion of cystinosis chromosomes in French Canada. Our analysis underlines the genetic heterogeneity of the French Canadian population, reflecting a frequently unrecognized contribution from non-Gallic sources including the Irish.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482956     DOI: 10.1038/sj.ejhg.5200349

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  11 in total

1.  The aminoglycoside geneticin permits translational readthrough of the CTNS W138X nonsense mutation in fibroblasts from patients with nephropathic cystinosis.

Authors:  Emma J Brasell; LeeLee Chu; Reyhan El Kares; Jung Hwa Seo; Robin Loesch; Diana M Iglesias; Paul Goodyer
Journal:  Pediatr Nephrol       Date:  2018-11-09       Impact factor: 3.714

2.  Cystinosis as a lysosomal storage disease with multiple mutant alleles: Phenotypic-genotypic correlations.

Authors:  Mohammad Al-Haggar
Journal:  World J Nephrol       Date:  2013-11-06

3.  The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region.

Authors:  C Phornphutkul; Y Anikster; M Huizing; P Braun; C Brodie; J Y Chou; W A Gahl
Journal:  Am J Hum Genet       Date:  2001-08-14       Impact factor: 11.025

Review 4.  The renal Fanconi syndrome in cystinosis: pathogenic insights and therapeutic perspectives.

Authors:  Stephanie Cherqui; Pierre J Courtoy
Journal:  Nat Rev Nephrol       Date:  2016-12-19       Impact factor: 28.314

5.  Genetic basis of cystinosis in Turkish patients: a single-center experience.

Authors:  Rezan Topaloglu; Thierry Vilboux; Turgay Coskun; Fatih Ozaltin; Brad Tinloy; Meral Gunay-Aygun; Aysin Bakkaloglu; Nesrin Besbas; Lambert van den Heuvel; Robert Kleta; William A Gahl
Journal:  Pediatr Nephrol       Date:  2011-07-24       Impact factor: 3.714

6.  Common mutation causes cystinosis in the majority of black South African patients.

Authors:  E Patricia Owen; Jenisha Nandhlal; Felicity Leisegang; George Van der Watt; Peter Nourse; Priya Gajjar
Journal:  Pediatr Nephrol       Date:  2014-10-18       Impact factor: 3.714

Review 7.  New aspects of the pathogenesis of cystinosis.

Authors:  Vasiliki Kalatzis; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2003-02-27       Impact factor: 3.714

Review 8.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

9.  The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis.

Authors:  Emma J Brasell; Lee Lee Chu; Murielle M Akpa; Idit Eshkar-Oren; Iris Alroy; Rachel Corsini; Brian M Gilfix; Yojiro Yamanaka; Pedro Huertas; Paul Goodyer
Journal:  PLoS One       Date:  2019-12-04       Impact factor: 3.240

Review 10.  Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review.

Authors:  Achini K Makuloluwa; Fatemeh Shams
Journal:  Clin Ophthalmol       Date:  2018-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.